Table I.

Table lists G6PD screening test outcomes at various thresholds of G6PD inhibition and the statistical noninferiority statistics of CSG vs FST at each level

% Normal G6PD activity	Test type	Test positive for deficiency	Test negative for deficiency	Number of tests	% Positive for deficiency	P value	Result
≤20%	FST	30	1	31	97%	0.058	Inconclusive
	CSG	31	0	31	100%
≤30%	FST	75	3	78	96%	0.006	Not inferior
	CSG	77	1	78	99%
≤40%	FST	101	11	112	90%	0.003	Not inferior
	CSG	107	5	112	96%
≤50%	FST	117	33	150	78%	0.001	Not inferior
	CSG	131	19	150	87%
≤60%	FST	119	60	179	67%	0.001	Not inferior
	CSG	137	42	179	77%
≤70%	FST	121	81	202	60%	0.001	Not inferior
	CSG	142	60	202	70%
≤80%	FST	121	97	218	56%	<0.001	Not inferior
	CSG	145	73	218	67%
≤90%	FST	122	110	232	53%	0.001	Not inferior
	CSG	146	86	232	63%
≤100%	FST	122	124	246	50%	0.001	Not inferior
	CSG	146	100	246	59%
>100%	FST	0	23	23	0%	0.443	Inconclusive
	CSG	0	23	23	0%

Abbreviations: CSG, CareStart G6PD; FST, fluorescent spot test; G6PD, glucose-6-phosphate dehydrogenase.